Design, synthesis and biological evaluation of novel scaffold benzo[4,5]imidazo [1,2-a]pyrazin-1-amine: Towards adenosine A2A receptor (A2A AR) antagonist

G Lakshma Reddy,Rupam Sarma,Shuhao Liu,Weifeng Huang,Jinping Lei,Jiasheng Fu,Wenhao Hu,G. Lakshma Reddy

DOI: https://doi.org/10.1016/j.ejmech.2020.113040

IF: 7.088

2021-01-01

European Journal of Medicinal Chemistry

Abstract:<p>Antagonists of adenosine receptor are under exploration as potential drug candidates for treatment of neurological disorders, depression, certain cancers and potentially used as a cancer immunotherapy. Herein, we describe design and synthesis of novel scaffold benzo[4,5]imidazo [1,2-<em>a</em>]pyrazin-1-amine (<strong>6</strong>) derivatives. All the compounds were evaluated for A_2A AR antagonist activity and displayed encouraging results (IC₅₀ 9–300 nM) of A_2A AR antagonist binding affinity in biochemical assay. Compound <strong>27</strong> exhibits good activity in A_2A AR antagonist cAMP functional assay (IC₅₀ 31 nM) and further this compound shows T-cell activation at the IL-2 production assay (EC₅₀ 165 nM). Molecular docking studies were carried out to rationalize the observed binding affinity of compound <strong>27</strong>.</p>

chemistry, medicinal